Black patients older than 65 are "consistently less likely" than comparable white patients to receive recommended cancer treatments, according to a new study published in the journal Cancer. The study, which examined treatments for more than 143,000 U.S. residents with lung, breast, colon, rectal or prostate cancer treated between 1992 and 2002 under Medicare, revealed some marked differences in the treatment of lung, colon and rectal cancers.
Among various disparities, researchers found that blacks with early-stage lung cancer were 19 percent less likely to have tumors surgically removed than whites. Blacks with rectal cancer were 27 percent less likely than whites to get chemotherapy after having tumor-removal surgery, and blacks with colon cancer were 24 percent less likely to get chemotherapy than whites after surgical removal of a tumor.
To learn more about the study:
- read this Kaiser Daily Health Policy Report piece
Related Articles:
Trend: States look for social roots of ethnic health disparities. Report
Study: California death rates vary by race. Report
Medical homes cut racial care disparities. Report
Racial disparities persist in health outcomes. Report
Medicare should help fix disparities. Report
Researchers fight for ethnic diversity in trials. Report
San Francisco tracks biggest killers of its ethnic groups. Article
